Back
Enterprise Financial Services Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
27
EFSC
Enterprise Financial Services
Last Price:
38.95
Seasonality Move:
1.95%
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
158.06
Seasonality Move:
18.65%
Sell
27
Enterprise Financial Services (EFSC)
is a Sell
Is Enterprise Financial Services a Buy, Sell or Hold?
- The current Enterprise Financial Services [EFSC] share price is $39.01. The Score for EFSC is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- EFSC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $157.96. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EFSC Stock Price Chart
What is Enterprise Financial Services's stock price today?
-
The Enterprise Financial Services share price today is $39.01
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EFSC is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $157.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
EFSC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 54.54 | Buy |
Chaikin Money Flow: | 85030 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.9 - 38.74) | Buy |
Bollinger Bands (100): | (38.25 - 40.05) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.07 | Buy |
Relative Strength Index (14 RSI): | 68.93 | Buy |
Chaikin Money Flow: | 909555 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (113.85 - 144.93) | Buy |
Bollinger Bands (100): | (118.68 - 136.96) | Buy |
EFSC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.5 | Buy |
20-day SMA: | 38.29 | Buy |
50-day SMA: | 38.87 | Buy |
200-day SMA: | 39.49 | Sell |
8-day EMA: | 38.56 | Buy |
20-day EMA: | 38.51 | Buy |
50-day EMA: | 38.79 | Buy |
200-day EMA: | 39.99 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 144.42 | Buy |
20-day SMA: | 131.3 | Buy |
50-day SMA: | 128.76 | Buy |
200-day SMA: | 115.64 | Buy |
8-day EMA: | 148.13 | Buy |
20-day EMA: | 137 | Buy |
50-day EMA: | 130.51 | Buy |
200-day EMA: | 121.04 | Buy |
Enterprise Financial Services Earnings Growth & EFSC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.73 per share, and an increase next year of $0.07 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
Enterprise Financial Services Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |